ATE214397T1 - Kristallisierung von alpha-l-aspartyl-l- phenylalaninmethylester aus wässerigen lösungen - Google Patents

Kristallisierung von alpha-l-aspartyl-l- phenylalaninmethylester aus wässerigen lösungen

Info

Publication number
ATE214397T1
ATE214397T1 AT95201794T AT95201794T ATE214397T1 AT E214397 T1 ATE214397 T1 AT E214397T1 AT 95201794 T AT95201794 T AT 95201794T AT 95201794 T AT95201794 T AT 95201794T AT E214397 T1 ATE214397 T1 AT E214397T1
Authority
AT
Austria
Prior art keywords
crystallization
aspartyl
alpha
methyl ester
phenylalanine methyl
Prior art date
Application number
AT95201794T
Other languages
English (en)
Inventor
Marinus Petrus Wilhelm Rijkers
Alexander Peter Marie Vrinzen
Original Assignee
Holland Sweetener Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holland Sweetener Co filed Critical Holland Sweetener Co
Application granted granted Critical
Publication of ATE214397T1 publication Critical patent/ATE214397T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
    • C07K5/0613—Aspartame

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95201794T 1995-06-30 1995-06-30 Kristallisierung von alpha-l-aspartyl-l- phenylalaninmethylester aus wässerigen lösungen ATE214397T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201794A EP0751146B1 (de) 1995-06-30 1995-06-30 Kristallisierung von alpha-L-aspartyl-L-phenylalaninmethylester aus wässerigen Lösungen

Publications (1)

Publication Number Publication Date
ATE214397T1 true ATE214397T1 (de) 2002-03-15

Family

ID=8220443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95201794T ATE214397T1 (de) 1995-06-30 1995-06-30 Kristallisierung von alpha-l-aspartyl-l- phenylalaninmethylester aus wässerigen lösungen

Country Status (9)

Country Link
US (1) US5733883A (de)
EP (1) EP0751146B1 (de)
KR (1) KR100426247B1 (de)
CN (1) CN1135237C (de)
AT (1) ATE214397T1 (de)
CA (1) CA2180207A1 (de)
DE (1) DE69525839T2 (de)
RU (1) RU2155771C2 (de)
TW (1) TW323270B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728862A (en) * 1997-01-29 1998-03-17 The Nutrasweet Company Method for preparing and purifying an N-alkylated aspartame derivative
IL122068A (en) * 1997-10-29 2001-01-28 Yissum Res Dev Co Process for the preparation of crystal form of aspartame
US6657073B1 (en) 1999-08-18 2003-12-02 Daesang Corporation Crystallization of α-L-aspartyl-L-phenylalanine methyl ester
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US9144251B2 (en) * 2005-11-23 2015-09-29 The Coca-Cola Company High-potency sweetener composition with mineral and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
EP1965667A2 (de) * 2005-11-23 2008-09-10 The Coca-Cola Company Synthetische süssmittelzusammensetzungen mit verbessertem zeitverlaufsprofil und/oder geschmacksprofil, verfahren zu ihrer formulierung und ihre verwendungen
US8956678B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with preservative and compositions sweetened therewith
US8993027B2 (en) * 2005-11-23 2015-03-31 The Coca-Cola Company Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT394854B (de) * 1986-06-12 1992-07-10 Biochemie Gmbh Verfahren zur herstellung von n-l-alpha-aspartyl-l-phenylalanin(nieder)alkylestern
JPH0832719B2 (ja) * 1986-12-19 1996-03-29 三井東圧化学株式会社 吸湿性の小さいα−Ｌ−アスパルチル−Ｌ−フエニルアラニンメチルエステルの製造法
JP2946853B2 (ja) * 1991-05-09 1999-09-06 味の素株式会社 アスパルテームの晶析法

Also Published As

Publication number Publication date
KR100426247B1 (ko) 2004-06-30
TW323270B (de) 1997-12-21
DE69525839T2 (de) 2002-10-31
KR970001370A (ko) 1997-01-24
EP0751146B1 (de) 2002-03-13
CN1135237C (zh) 2004-01-21
US5733883A (en) 1998-03-31
DE69525839D1 (de) 2002-04-18
EP0751146A1 (de) 1997-01-02
CA2180207A1 (en) 1996-12-31
CN1143649A (zh) 1997-02-26
RU2155771C2 (ru) 2000-09-10

Similar Documents

Publication Publication Date Title
DE69525839D1 (de) Kristallisierung von alpha-L-aspartyl-L-phenylalaninmethylester aus wässerigen Lösungen
DE69330963D1 (de) Herstellung von aluminosilikatzeolithen
FI950957A0 (fi) Menetelmä ksyloosin kiteyttämiseksi vesiliuoksista
BR8404126A (pt) Processo para a separacao de iodo e seus compostos dos produtos de carbonilacao acido acetico,anidrido acetico ou diecetato de etilideno,obtidos na carbonilacao de eter dimetilico,acetato de metila ou metanol
RU96112765A (ru) СПОСОБ КРИСТАЛЛИЗАЦИИ МЕТИЛОВОГО ЭФИРА α-L-АCПАРТИЛ-L- ФЕНИЛАЛАНИНА ИЗ ВОДНОГО РАСТВОРА
ATE82547T1 (de) Herstellung von hoch-kristallisierten, geformten polyarylenthioether-produkten.
ES2124283T3 (es) Cristalizacion de fructosa.
FI914026A0 (fi) Foerfarande foer framstaellning av genomsynlig reglerad mjoelkvassleprotein och reglerad mjoelkvassleproteinprodukt.
DK163303C (da) Fremgangsmaade til fremstilling af cimetidin polymorf b.
FR2352059A1 (fr) Procede et dispositif pour l'inoculation de solutions sucrees sursaturees pour la cristallisation
AU7881481A (en) Recovery of l-phenylalanine and l-aspartic acid
KR850004099A (ko) L(-)카르니틴 염산염과 l(-)카르니틴 분자내염의 제조방법
DK0913385T3 (da) Fremgangsmåde til fremstilling af citronsyre og/eller citrater
EP0256517A3 (de) Verfahren zur Herstellung von stabilem alpha-L-Aspartyl-L-phenylalaninmethylester
KR960010666A (ko) O, s-디메틸 n-아세틸포스포르아미도티오에이트의 정제방법
MX9602537A (es) Cristalizacion del ester meitlico de la alfa-l-aspartil-l-fenilalanina partiendo de soluciones acuosas.
JPS52118464A (en) Alpha-substituted aminoalkanyloxyindole derivatives and method of preparing the same
SU960185A1 (ru) Способ получени 1-трифенилфосфоранилиден-4-ароил-5-карбэтоксициклопент-4-ен-2,3-дионов
DE69215444D1 (de) Verfahren zur Kristallisation von Alpha-L-Aspartyl-L-Phenylalaninmethylester
JPS54115349A (en) Cyclohexane derivative, its preparation and herbicide containing the same
ATE154795T1 (de) Silbernitrat, hergestellt durch ein kontinuierliches verdampfungs- kristallisationsverfahren
JPS53119782A (en) Crystallizing method for solution containing salt
Mikami et al. Recovery and Re-Use Process for Waste Sulfuric Acid from Anodizing Aluminum, Using a Completely Closed System
DE69111340D1 (de) Mono-N,N-dimethyl-4-aminopyridinium sn Glycerol-3-phosphat, seine Herstellung und Verwendung bei der Herstellung von Phosphatidsäuren.
FR2524268B1 (fr) Procede et installation de preparation de caseinates acides